Table 5.
Background characteristics of the participants in each group (stratified analysis).
| Young participants (under 40 years) | Middle-aged participants (40 years and older) | ||||||
|---|---|---|---|---|---|---|---|
| Placebo group | LG2055 group | p-value | Placebo group | LG2055 group | p-value | ||
| n = 32 | n = 28 | n = 61 | n = 67 | ||||
| Sex | Male/female | 14/18 | 12/16 | 1.000 | 30/31 | 32/35 | 1.000 |
| Age | Years | 31.3 ± 4.8 | 29.5 ± 3.8 | 0.107 | 53.9 ± 7.1 | 52.0 ± 6.5 | 0.129 |
| Height | cm | 164.3 ± 8.0 | 165.8 ± 7.1 | 0.458 | 164.1 ± 8.6 | 163.6 ± 8.2 | 0.743 |
| Weight | kg | 56.9 ± 9.5 | 57.9 ± 10.2 | 0.685 | 59.8 ± 12.3 | 58.0 ± 11.0 | 0.368 |
| BMI | kg/m2 | 21.0 ± 2.4 | 20.9 ± 2.4 | 0.969 | 22.0 ± 3.1 | 21.5 ± 2.7 | 0.294 |
Values are presented as the mean ± SD.